// App-Quantinova.ai

e16103 : What predicts minimal response to abiraterone in metastatic castrate resistant prostate cancer?

Researchers

Presenter

  • Rhian Sian Davies

Principal Investigators

  • Christian Smith

  • Jim Barber

  • Nachi Palaniappan

  • John Staffurth

  • Jason Francis Lester

  • Ricky Dylan Frazer

  • Mick Button

  • Jacob Tanguay

Medical Centers

  • Singleton Hospital, Swansea, United Kingdom

  • Velindre Cancer Centre, Cardiff, WalesVelindre Hospital, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Bicalutamide

  • Prednisolone

  • CB-7598

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved